Loading...

Follow Mesothelioma Help Now | Malignant Mesothelioma .. on Feedspot

Continue with Google
Continue with Facebook
or

Valid

Surgery for pleural mesothelioma is a standard treatment as it’s the best way to remove the majority of tumors from the body. However, relapse after surgery is common. A recent study has found adjuvant radiation for pleural mesothelioma (radiation given after surgery) results in higher survival rates. Radiation as Part of Multimodal Therapy When a

The post Study Finds Adjuvant Radiation for Pleural Mesothelioma Improves Survival appeared first on Mesothelioma Help Now.

Read Full Article
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 

The Pacific Mesothelioma Center (PMC) in Los Angeles, California has been issued a U.S. patent for a new treatment—mesothelioma stem cell therapy. The center at the Pacific Heart, Lung and Blood Institute can now offer mesenchymal stem cell treatment and clinical research opportunities to patients with pleural mesothelioma. New Treatments Provide New Hope Stem cell

The post Pacific Mesothelioma Center Receives Patent for Mesothelioma Stem Cell Therapy appeared first on Mesothelioma Help Now.

Read Full Article
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 

The European Union (EU) has awarded Aromics—a Spanish biotechnology company—€1 million (Euros) for its BERMES project that’s working on a novel mesothelioma drug. These funds will allow the company to finish its preclinical trials for this new drug, NAX035. The medical community needs to find effective targeted mesothelioma therapies because the disease has such a

The post Preclinical Trial for New Mesothelioma Drug Receives EU Funding appeared first on Mesothelioma Help Now.

Read Full Article
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 

The annual International Symposium on Malignant Mesothelioma is coming up—March 25-27, 2019, in Bethesda, MD. This mesothelioma symposium brings together mesothelioma patients, their families, doctors and scientists and allows the community to learn about the latest research from the individuals conducting it. The Mesothelioma Symposium is an essential event for the research community and the

The post Upcoming Annual International Mesothelioma Symposium appeared first on Mesothelioma Help Now.

Read Full Article
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 

Chinese researchers have discovered a connection between a patient’s nutrition and peritoneal mesothelioma prognosis. The medical community has always encouraged cancer patients to have healthy nutrition. Now researchers and doctors are getting closer to understanding how important that is and why. The study measured patients’ overall nutrition and tested protein levels from the fluid buildup

The post Study Finds Nutrition Is an Important Factor in Peritoneal Mesothelioma Prognosis appeared first on Mesothelioma Help Now.

Read Full Article
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 

The Mesothelioma Applied Research Foundation (MARF) announced the recipients of the 2018 mesothelioma research grants: The first program to receive funding is called “Using gene expression to predict successful responses to chemoimmunotherapy”—a study that examines how a patient’s genes determine the success of their treatment. The second project will look into “Genetic variants, pathways, and

The post Two New Mesothelioma Research Programs Receive Funding appeared first on Mesothelioma Help Now.

Read Full Article
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 

A mesothelioma patient has received a first dose of the CA-170 immunotherapy drug in a Phase 1 trial looking at patients with various advanced tumors and lymphomas, including a mesothelioma cohort (a group of mesothelioma patients). Curis, Inc.—a biotechnology company that focuses on treatments for cancer—announced that the first mesothelioma patient was dosed in the

The post First Mesothelioma Patient Undergoes “CA-170” Immunotherapy Drug in Clinical Trial appeared first on Mesothelioma Help Now.

Read Full Article
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 

A new study out of France is looking at how effective it is to use a combination of nivolumab and ipilimumab immunotherapy drugs for mesothelioma after the patient received chemotherapy. Nivolumab alone has already shown promise in mesothelioma patients who have stopped responding to chemotherapy. Chemotherapy is the first-line treatment for mesothelioma. However, it only

The post Phase 2 Trial Tests Immunotherapy Drugs for Mesothelioma Patients Who Have Relapsed appeared first on Mesothelioma Help Now.

Read Full Article
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 

PMC Symposium Highlights New Mesothelioma Research, Clinical Trials UCLA and the Pacific Mesothelioma Center (PMC) hosted the 8th International Symposium on Malignant Pleural Mesothelioma at UCLA’s Meyer and Renee Luskin Conference Center on the last weekend of September 2018. The conference saw doctors from around the world showcase new findings related to pleural mesothelioma. Doctors

The post PMC Mesothelioma Symposium appeared first on Mesothelioma Help Now.

Read Full Article
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 

Researchers at the Cancer Research UK Cambridge Center are currently recruiting the first participants for a new clinical trial to develop a cancer breath test. The breath test could aid in the early detection of multiple cancers and reduce the need for invasive diagnostic procedures like surgical biopsies. How Cancer Breath Testing Works Researchers are

The post Revolutionary Cancer Breath Test Moves to Clinical Trials appeared first on Mesothelioma Help Now.

Read Full Article

Read for later

Articles marked as Favorite are saved for later viewing.
close
  • Show original
  • .
  • Share
  • .
  • Favorite
  • .
  • Email
  • .
  • Add Tags 

Separate tags by commas
To access this feature, please upgrade your account.
Start your free month
Free Preview